Skip to main content

Incidence du cancer du testicule au niveau mondial

Worldwide incidence of testicular cancer


Bien que le cancer du testicule fasse partie des tumeurs rares, il représente la tumeur la plus fréquente de l’homme jeune. Dans le monde, les pays européens, l’Amérique du Nord, l’Australie et la Nouvelle-Zélande montrent une forte incidence du cancer du testicule. Les données recueillies dans les pays en voie de développement sont encore très parcellaires, mais elles semblent confirmer que les hommes africains et asiatiques ont une incidence du cancer du testicule plus faible que les hommes caucasiens. Cette incidence paraît augmenter depuis le début du siècle dans les pays occidentaux avec une accentuation de cette tendance depuis les années 50. L’augmentation de l’incidence affecte particulièrement la classe d’âge des adolescents et des hommes jeunes. Les raisons de cette variation et de l’augmentation de l’incidence du cancer du testicule constatée dans de nombreux pays restent inconnues, bien que de forts soupçons pèsent sur des facteurs environnementaux, qui pourraient également retentir sur la fertilité masculine.


Testicular cancer (TC) is the commonest malignancy in men aged 20 to 34 years. We reviewed the statistical sources of the IARC, and summarized the published studies on the increasing incidence rates of TC in the world.

We observed a variation of incidence rates according to the geographical situation. The majority of industrialized countries, North-America, Europe, and Oceania showed higher incidence rates than Asian or African countries. Nevertheless, surprising differences in TC incidence rates were observed between neighboring countries and also between different regions in the same country. Substantial differences in TC incidence were also observed between ethnic groups.

A clear trend towards an increase in TC incidence over the last decades was revealed. The increase in TC incidence was associated with a strong birth cohort effect in the USA, and also in European countries.

Previous studies have not been able to explain the variation of worldwide incidence rates and its increase. Although male reproductive abnormalities assumed to be related to exposure to high levels of endogenous oestrogens during pregnancy, further studies are required before any conclusions can be drawn.


  1. 1.

    ADAMI H.O., BERGSTROM R., MOHNER M. et al.: Testicular cancer in nine northern European countries. Int. J. Cancer, 1994, 59: 33–38.

    PubMed  Article  CAS  Google Scholar 

  2. 2.

    BERGSTROM R., ADAMI H.O., MOHNER M. et al.: Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J. Nat. Cancer Inst., 1996, 88–96.

  3. 3.

    BERRINO F., CAPCACCIA R., ESTEVE J. et al.: Survival of Cancer Patients in Europe: the EUROCARE-2 Study, IARC Scientific Publications No. 151, Lyon, IARC Press, 1999.

    Google Scholar 

  4. 4.

    BOSL G.J., MOTZER R.J.: Testicular germ-cell cancer. N. Eng. J. Med., 1997, 337: 242–253.

    Article  CAS  Google Scholar 

  5. 5.

    DOS SANTOS SILVA I., SWERDLOW A.J., STILLER C.A., REID A.: Incidence of testicular germ-cell malignancies in England and Wales: trends in children compared with adults. Int. J Cancer, 1999, 83: 630–634.

    PubMed  Article  CAS  Google Scholar 

  6. 6.

    FERLAY J., BRAY F., PISANI P., PARKIN D.M.: GLOBOCAN 2000 Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0, IARC CancerBase No. 5, Lyon, IARC Press, 2001.

    Google Scholar 

  7. 7.

    FIALA J.: The incidence of cancer in the Czech Republic from 1973 to 1989: cancers with non-parallet trends in age groups. Centr. Eur. J. Publ. Hlth, 1996, 4: 157–193.

    CAS  Google Scholar 

  8. 8.

    HARDING M., HOLE D., GILLIS C.: The epidemiology of non-seminomatous germ cell tumours in the west of Scotland 1975–89. Br. J. Cancer, 1995, 72: 1559–1562.

    PubMed  CAS  Google Scholar 

  9. 9.

    HENDERSON B.E., ROSS R.K., YU M.C. et al.: An explanation for the increasing incidence of Testis Cancer: decreasing age at first full-term pregnancy. J. Nat. Cancer Inst., 1997, 89: 818–819.

    PubMed  Article  CAS  Google Scholar 

  10. 10.

    HOFF WANDERAS E., TRETLI S., FOSSA S.D.: Trends in incidence of testicular cancer in Norway 1955–1992. Eur. J. Cancer, 1995, 31A: 2044–2048.

    Article  Google Scholar 

  11. 11.

    LEVI F., TE V.C., LA VECCHIA C: Testicular cancer trends in the Canton of Vaud, Switzerland, 1974–1987. Br. J. Cancer, 1990, 62: 871–873.

    PubMed  CAS  Google Scholar 

  12. 12.

    MCCREDIE M., COATES M.S., DAY P., BELL J.C.: Changes in cancer incidence and mortality in New South Wales. Med. J. Aus., 1995, 163: 520–523.

    CAS  Google Scholar 

  13. 13.

    MCCREDIE M., COATES M.S., FORD J.: Cancer incidence in New Zealand born residents of New South Wales. N.Z. Med. J., 1990, 103: 61–63.

    PubMed  CAS  Google Scholar 

  14. 14.

    MCKIERNAN J.M., GOLUBOFF E.T., LIBERSON G.L., et al.: Rising risk of testicular cancer by birth cohort in the United States from 1973 to 1995. J. Urol., 1999, 162: 361–363.

    PubMed  Article  CAS  Google Scholar 

  15. 15.

    MOLLER H., SKAKKEBAEK N.: Risk of testicular cancer in subfertile men: case-control study. Br. Med. J., 1999, 318: 559–562.

    CAS  Google Scholar 

  16. 16.

    MOLLER H., JORGENSEN N., FORMAN D.N.: Trends in incidence of testicular cancer in boys and adolescent men. Int. J. Cancer, 1995, 68: 761–764.

    Article  Google Scholar 

  17. 17.

    NAKATA S., OHTAKE N., KUBOTA Y., IMAI K., YAMANAKA H., ITO Y., HIRAYAMA N., HASEGAWA K.: Incidence of urogenital cancers in Gunma prefecture, Japan: a 10-year summary. Int. J. Urol., 1998, 5: 364–369.

    PubMed  Article  CAS  Google Scholar 

  18. 18.

    NETHERSELL A.B.W., DRAKE L.K., SIKORA K.: The increasing incidence of testicular cancer in East Anglia. Br. J. Cancer, 1984, 50: 377–380.

    PubMed  CAS  Google Scholar 

  19. 19.

    PARKIN D.M., WHELAN S.L., FERLAY J., et al.: Cancer Incidence in Five Continents Vol. VII, IARC Scientific Publications No. 143, Lyon, IARC Press, 1997.

    Google Scholar 

  20. 20.

    PHARRIS-CIUREJ N.D., COOK L.S., WEISS N.S.: Incidence of Testicular Cancer in the United States: has the epidemic begun to abate? Am. J. Epidemiol., 1999, 150: 45–46.

    PubMed  CAS  Google Scholar 

  21. 21.

    PLESKO I., ONDRUS D., BOYLE P.: Testicular-cancer incidence and mortality in Slovakia, 1968–90. Lancet, 1996, 347: 900–901.

    PubMed  Article  CAS  Google Scholar 

  22. 22.

    POLEDNAK A.P.: Trends in cancer incidence in Connecticut, 1935–1991. Cancer, 1994, 74: 2863–2872.

    PubMed  Article  CAS  Google Scholar 

  23. 23.

    POWER D.A., BROWN R.S.D., BROCK C.S., PAYNE H.A., MAJEED A., BABB P.: Trends in testicular carcinoma in England and Wales, 1971–99. Br. J. Urol. Int., 2001, 87: 361–365.

    CAS  Google Scholar 

  24. 24.

    PRENER A., STORM H.H., NIELSEN N.H.: Cancer of the male genital tract in circumpolar inuit. Acta Oncol., 1996, 35: 589–593.

    PubMed  Article  CAS  Google Scholar 

  25. 25.

    SENTURIA Y.D.: The epidemiology of testicular cancer. Br. J. Urol., 1987, 60: 285–291.

    PubMed  Article  CAS  Google Scholar 

  26. 26.

    SHARPE R.M., SKAKKEBAEK N.E.: Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet, 1993, 341: 1392–1395.

    PubMed  Article  CAS  Google Scholar 

  27. 27.

    SONEVELD D.J.A., SCHAAPVELD M., SLEIJFER D.T.H., et al.: Geographic clustering of testicular cancer incidence in the northern part of the Netherlands. Br. J. Cancer, 1999, 81: 1262–1267.

    Article  Google Scholar 

  28. 28.

    STONE J.M., CRUICKSHANK D.G., SANDEMAN T.F., et al.: Trebling of the incidence of testicular cancer in Victoria, Australia (1950–1985). Cancer, 1991, 68: 211–219.

    PubMed  Article  CAS  Google Scholar 

  29. 29.

    STONE J.M., SANDEMAN T.F., IRONSIDE P., et al.: Time trends in accuracy of classification of testicular tumours, with clinical and epidemiological implications. Br. J. Cancer, 1992, 66: 396–401.

    PubMed  CAS  Google Scholar 

  30. 30.

    SWERDLOW A.J., DOS SANTOS SILVA I., REID A., QIAO Z., BREWSTER D.H., ARRUNDALE J.: Trends in cancer incidence and mortality in Scotland: description and possible explanations. Br. J. Cancer, 77, 1998, Supp. 3: 1–16.

    PubMed  Google Scholar 

  31. 31.

    VAN DEN EEDEN S.K., WEISS N.S.: Is testicular cancer incidence in blacks increasing? Am. J. Pub. Hlth, 1989, 79: 1553–1554.

    Article  Google Scholar 

  32. 32.

    WATERHOUSE J.A.: Epidemiology of testicular tumours. J. Roy. Soc. Med., 1985, 78 Supp. 6: 3–7.

    Google Scholar 

  33. 33.

    WATERHOUSE, J. MUIR C., CORREA P., POWELL J.: Cancer Incidence in Five Continents Vol. III, IARC Scientific Publications No. 15, Lyon, IARC Press, 1978.

    Google Scholar 

  34. 34.

    WEIR H.K., MARRETT L.D., MORAVAN V.: Trends in the incidence of testicular germ cell cancer in Ontario by histologic subgroup, 1964–1996. Can. Med. Ass. J., 1999, 160: 201–205.

    CAS  Google Scholar 

  35. 35.

    WILKINSON T.J., COLLS B.M., SCHLUTTER P.J.: Increased incidence of germ cell testicular cancer in New Zealand Maoris. Br. J. Cancer, 1992, 65: 769–771.

    PubMed  CAS  Google Scholar 

  36. 36.

    ZATONSKI W., JEZIORSKI K., TYCZYNSKI J.: Testicular cancer in Poland. Lancet, 1990, 336: 183.

    PubMed  Article  CAS  Google Scholar 

  37. 37.

    ZHENG T., HOLFORD T.R., MA Z., et al.: Continuing increase in incidence of germ-cell testis cancer in young adults: experience from Connecticut, USA, 1935–1992. Int. J. Cancer, 1996, 65: 723–729.

    PubMed  Article  CAS  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Tomohiro Matsuda.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Matsuda, T., Huyghe, E. & Thonneau, P. Incidence du cancer du testicule au niveau mondial. Androl. 12, 149–155 (2002).

Download citation

Mots clés

  • cancer du testicule
  • incidence
  • épidémiologie


  • Testicular cancer
  • incidence
  • epidemiology